168 related articles for article (PubMed ID: 31357912)
1. Structural dynamics behind variants in pyrazinamidase and pyrazinamide resistance.
Khan MT; Malik SI
J Biomol Struct Dyn; 2020 Jul; 38(10):3003-3017. PubMed ID: 31357912
[TBL] [Abstract][Full Text] [Related]
2. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.
Khan MT; Khan A; Rehman AU; Wang Y; Akhtar K; Malik SI; Wei DQ
Sci Rep; 2019 May; 9(1):7482. PubMed ID: 31097767
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis of A46V, H57Y, and D129N in pyrazinamidase associated with pyrazinamide resistance.
Khan MT; Chinnasamy S; Cui Z; Irfan M; Wei DQ
Saudi J Biol Sci; 2020 Nov; 27(11):3150-3156. PubMed ID: 33100877
[TBL] [Abstract][Full Text] [Related]
4. Pyrazinamide resistance and mutations in pncA among isolates of Mycobacterium tuberculosis from Khyber Pakhtunkhwa, Pakistan.
Khan MT; Malik SI; Ali S; Masood N; Nadeem T; Khan AS; Afzal MT
BMC Infect Dis; 2019 Feb; 19(1):116. PubMed ID: 30728001
[TBL] [Abstract][Full Text] [Related]
5. pncA gene expression and prediction factors on pyrazinamide resistance in Mycobacterium tuberculosis.
Sheen P; Lozano K; Gilman RH; Valencia HJ; Loli S; Fuentes P; Grandjean L; Zimic M
Tuberculosis (Edinb); 2013 Sep; 93(5):515-22. PubMed ID: 23867321
[TBL] [Abstract][Full Text] [Related]
6. Free energy landscape and thermodynamics properties of novel mutations in PncA of pyrazinamide resistance isolates of
Tahir Khan M; Dumont E; Chaudhry AR; Wei DQ
J Biomol Struct Dyn; 2023 Oct; ():1-12. PubMed ID: 37837425
[TBL] [Abstract][Full Text] [Related]
7. Estimation of pyrazinamidase activity using a cell-free
Rueda D; Bernard C; Gandy L; Capton E; Boudjelloul R; Brossier F; Veziris N; Zimic M; Sougakoff W
Int J Mycobacteriol; 2018; 7(1):16-25. PubMed ID: 29516881
[TBL] [Abstract][Full Text] [Related]
8. Pyrazinamide resistance of novel mutations in
Ali A; Khan MT; Khan A; Ali S; Chinnasamy S; Akhtar K; Shafiq A; Wei DQ
RSC Adv; 2020 Sep; 10(58):35565-35573. PubMed ID: 35515677
[TBL] [Abstract][Full Text] [Related]
9. Structural Dynamics Behind Clinical Mutants of PncA-Asp12Ala, Pro54Leu, and His57Pro of
Mehmood A; Khan MT; Kaushik AC; Khan AS; Irfan M; Wei DQ
Front Bioeng Biotechnol; 2019; 7():404. PubMed ID: 31921809
[TBL] [Abstract][Full Text] [Related]
10. Insights from the molecular mechanism of pyrazinamide to mutated pyrazinamidase linked to the
Pitaloka DAE; Arfan A; Ramadhan DSF; Chaidir L
J Biomol Struct Dyn; 2024; 42(2):759-765. PubMed ID: 37096659
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis isolates from Rio de Janeiro reveal unusually low correlation between pyrazinamide resistance and mutations in the pncA gene.
Bhuju S; Fonseca Lde S; Marsico AG; de Oliveira Vieira GB; Sobral LF; Stehr M; Singh M; Saad MH
Infect Genet Evol; 2013 Oct; 19():1-6. PubMed ID: 23770140
[TBL] [Abstract][Full Text] [Related]
12. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
[TBL] [Abstract][Full Text] [Related]
13. Insight into novel clinical mutants of RpsA-S324F, E325K, and G341R of
Khan MT; Rehaman AU; Junaid M; Malik SI; Wei DQ
Comput Struct Biotechnol J; 2018; 16():379-387. PubMed ID: 30402208
[TBL] [Abstract][Full Text] [Related]
14. Role of pncA gene mutations W68R and W68G in pyrazinamide resistance.
Aggarwal M; Singh A; Grover S; Pandey B; Kumari A; Grover A
J Cell Biochem; 2018 Mar; 119(3):2567-2578. PubMed ID: 28980723
[TBL] [Abstract][Full Text] [Related]
15. Insights into the Mechanisms of the Pyrazinamide Resistance of Three Pyrazinamidase Mutants N11K, P69T, and D126N.
Junaid M; Khan MT; Malik SI; Wei DQ
J Chem Inf Model; 2019 Jan; 59(1):498-508. PubMed ID: 30481017
[TBL] [Abstract][Full Text] [Related]
16. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis.
Scorpio A; Lindholm-Levy P; Heifets L; Gilman R; Siddiqi S; Cynamon M; Zhang Y
Antimicrob Agents Chemother; 1997 Mar; 41(3):540-3. PubMed ID: 9055989
[TBL] [Abstract][Full Text] [Related]
17. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of
Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582
[TBL] [Abstract][Full Text] [Related]
18. Reduced pyrazinamidase activity and the natural resistance of Mycobacterium kansasii to the antituberculosis drug pyrazinamide.
Sun Z; Zhang Y
Antimicrob Agents Chemother; 1999 Mar; 43(3):537-42. PubMed ID: 10049264
[TBL] [Abstract][Full Text] [Related]
19. pncA mutations in clinical Mycobacterium tuberculosis isolates from Korea.
Park SK; Lee JY; Chang CL; Lee MK; Son HC; Kim CM; Jang HJ; Park HK; Jeong SH
BMC Infect Dis; 2001; 1():4. PubMed ID: 11429043
[TBL] [Abstract][Full Text] [Related]
20. [Characteristics of pncA gene in multidrug-resistant Mycobacterium tuberculosis isolates and its correlation with drug resistance to pyrazinamide].
Hong CY; Wang F; Gui J; Liu XL
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 May; 46(5):436-9. PubMed ID: 22883731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
